DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
6th Annual Chicago Sickle Cell Summit
Date & Time
Sep 28, 2023 11:00 AM in Eastern Time (US and Canada)
Description
The theme for this year’s summit is “Thriving with Sickle Cell Disease: Optimizing Care Through all Stages of Life.”
The goal is to highlight the latest trends, successes, challenges, and barriers to propel the lives of the Sickle Cell community beyond survival/sustenance to thriving.
The goal is to highlight the latest trends, successes, challenges, and barriers to propel the lives of the Sickle Cell community beyond survival/sustenance to thriving.
Keynote speaker: Wanda Whitten-Shurney, CEO and Medical Director of SCDAA-MI
Session 1: Genetics and Foundations of Care Featured speakers – Kay Saving, Marwah Farooqui, Lewis Hsu
Session 2: Emerging Care, Medicines, and Treatments Featured speakers – Franklin Njoku, Damiano Rondelli, Joseph Colla
Session 3: Building Community Partnerships through Training
We are offering a maximum of 4 CE credits for providers. Please indicate your request for credits in the exit survey.
The summit is free for all participants.
Share
+myBinderRelated Content
-
education & researchAdverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatmentThe prognosis of sickle cell anemia (SCA...
-
education & researchPain and opioid use after reversal of sickle cell disease following hematopoietic stem cell transplantPain is the most common symptom of sickl...
-
news & eventsEndari reduces pain crises, hospitalizations in sickle cell patients, phase 3 trial showsTreatment with Endari (L-glutamine) le...
-
news & eventsAPS Scientific Meeting 2019The American Pain Society will hold its ...
-
videos & visualsSickle Cell Patients are Innocent Victims of the Opioid Epidemic: Samir K. Ballas, MDhttps://www.youtube.com/watch?v=BOhY_gJo...
-
news & eventsSickle Cell Anemia Toddlers Benefit from Maximal Hydroxyurea Doses, Study FindsIntensifying treatment with hydroxyurea ...
-
news & eventsGlobal Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.